Skip to content

Prevention, Management and Rehabilitation of Knee Osteoarthritis at the Workplace

Prevention, Management and Rehabilitation of Knee Osteoarthritis at the Workplace

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05822401
Enrollment
80
Registered
2023-04-20
Start date
2023-04-11
Completion date
2023-12-31
Last updated
2023-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Discomfort, Knee Osteoarthritis, Knee Pain Chronic

Brief summary

The goal of this intervention study is to assess the effect of blood flow restricted (BFR) exercise integrated into the daily work tasks among hospital workers with or at increased risk of chronic knee pain. The main questions are: Can BFR exercise integrated into the daily work tasks reduce knee pain (primary outcome) and improve function and work ability among hospital workers with or at increased risk of chronic knee pain? Participants in the intervention group will for shorts bouts during their workdays integrate BFR into their daily work tasks involving walking, whereas the control group will continue as usual.

Interventions

Blood flow restricted training integrated into the daily work tasks for 8 weeks.

Will continue their work as usual

Sponsors

University of Southern Denmark
CollaboratorOTHER
University Hospital Bispebjerg and Frederiksberg
CollaboratorOTHER
National Research Centre for the Working Environment, Denmark
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 67 Years
Healthy volunteers
Yes

Inclusion criteria

* Hospital workers working at least 20 hours per week with or without chronic knee pain (\>3 months)

Exclusion criteria

* Life-threatening disease * Conditions where BFR training may be contraindicated, e.g. pregnancy, cancer, diabetes, major cardiovascular disease, current, previous or family history of clotting disorders, recent immobilization, major surgery or injections into the joint (i.e. corticosteroid injection) * Systolic/diastolic blood pressure above 160/100 mmHg

Design outcomes

Primary

MeasureTime frameDescription
Pain intensityChange pre-post 8 weeks of interventionChange in worst knee pain intensity during the last week rated on a 11-point numeric rating scale (NRS)

Secondary

MeasureTime frameDescription
Functional performanceChange pre-post 8 weeks of intervention30-s chair-stand test, 40 m fast-paced walk test, a stair-climb test, maximal isometric knee extensor muscle strength
Work abilityChange pre-post 8 weeks of interventionSingle-item on physical work ability derived from the Work Ability Index (WAI)

Other

MeasureTime frameDescription
Work-related fatigueChange pre-post 8 weeks of interventionRating af work-related fatigue in different body parts
Work-limiting painChange pre-post 8 weeks of interventionRating of the degree of work limitations due to pain

Contacts

Primary ContactSebastian Skovlund
svs@nfa.dk40385166

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026